Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,880,000
+$2,208,672 QoQ
Shares Held
1,000,000
-33.2% QoQ
Ownership
0.662%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#33
of 294 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. BHVN ranks #65 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in BHVN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,880,000 | 1,000,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,671,328 | 1,497,793 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,693,500 | 150,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,913,095 | 1,260,033 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,889,765 | 630,033 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,254,718 | 551,361 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $21,476,250 | 575,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $74,079,775 | 1,482,485 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $66,410,955 | 1,913,309 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $107,411,597 | 1,964,008 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $86,483,563 | 2,020,644 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $32,306,370 | 1,242,075 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $35,408,895 | 1,480,305 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $16,576,560 | 1,213,511 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,786,732 | 1,353,511 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||